Zasocitinib: Clinical Trials

4 recruiting, 1 active not recruiting. 5 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	5	Recruiting 4, Active not recruiting 1

Follow Zasocitinib: new trials by email Literature Review of Zasocitinib trials Research Report on Zasocitinib

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study of Zasocitinib (TAK-279) in Adults With Active Crohn's Disease Zasocitinib - Crohn's Disease	Phase 2	Recruiting	Takeda	20	2026-08-13	2026-08-24
A Study of Zasocitinib in Adults With Nonsegmental Vitiligo Zasocitinib, Placebo - Nonsegmental Vitiligo	Phase 2	Recruiting	Takeda	200	2025-11-03	2026-09-30
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD) Zasocitinib - Crohn's Disease, Ulcerative Colitis	Phase 2	Recruiting	Takeda	192	2025-05-28	2026-05-22
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis TAK-279, Placebo - Ulcerative Colitis	Phase 2	Active not recruiting	Takeda	213	2024-03-29	2026-08-17
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease TAK-279, Placebo - Crohn's Disease	Phase 2	Recruiting	Takeda	268	2024-03-05	2026-09-25

Conditions studied

Crohn Disease (3)  ·  Colitis, Ulcerative (2)

Sponsors

Takeda (5)

Countries

China (4)  ·  Poland (4)  ·  United States (4)  ·  Canada (3)  ·  Czechia (3)  ·  France (3)  ·  Hungary (3)  ·  Italy (3)  ·  Japan (3)  ·  Slovakia (3)  ·  South Korea (3)  ·  United Kingdom (3)  ·  Australia (2)  ·  Belgium (2)  ·  Bulgaria (2)

NIH funding

2023 (2), 2025 (1)